Registration
GARY BUEHLER for TEVA PHARMACEUTICALS USA, INC.
Firm
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Section 505(b)(2) new drug applications and exclusivity period.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY BUEHLER New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LTD. | Israel | Israel | 100.0% | — |
| TEVA PHARMACEUTICALS EUROPE BV | Netherlands | Netherlands | 100.0% | — |
| ORVET UK | United Kingdom | United Kingdom | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.